MARKET

MEDXF

MEDXF

Medexus Pharmace
OTCQX
3.460
-0.120
-3.35%
Opening 10:40 07/01 EDT
OPEN
3.460
PREV CLOSE
3.580
HIGH
3.460
LOW
3.460
VOLUME
100
TURNOVER
346
52 WEEK HIGH
3.580
52 WEEK LOW
1.850
MARKET CAP
110.81M
P/E (TTM)
-329.5238
1D
5D
1M
3M
1Y
5Y
1D
Weekly Report: what happened at MEDXF last week (0622-0626)?
Weekly Report · 2d ago
Medexus Pharma publishes FY 2026 MD&A report for year ended March 31, 2026
PUBT · 5d ago
Canada's Medexus Q4 revenue misses analyst expectations, net loss widens
Reuters · 5d ago
Medexus Pharmaceuticals reports Q4 results
Seeking Alpha · 5d ago
Medexus FY26 net loss widens to US$2.4 million; revenue falls 8.3% to US$99.3 million
PUBT · 5d ago
MEDEXUS PHARMACEUTICALS Q4 REVENUE USD 24.652 MILLION VS. IBES ESTIMATE USD 25.6 MILLION
Reuters · 5d ago
Medexus Announces Fiscal Year 2026 Results, Demonstrating Continued Momentum and Strong Product-Level Performance of GRAFAPEX (treosulfan) for Injection
Newsfile · 5d ago
Weekly Report: what happened at MEDXF last week (0615-0619)?
Weekly Report · 06/22 10:02
More
About MEDXF
Medexus Pharmaceuticals Inc. is a Canada-based specialty pharmaceutical company with a North American commercial platform. The Company has a portfolio of rare disease treatment solutions. Its focus is on the therapeutic areas of hematology-oncology and allergy, dermatology, and rheumatology. It operates through two product portfolios: Medexus Pharma Canada and Medexus Pharma. Its lead products are IXINITY (US), GRAFAPEX (US), Trecondyv (Canada), Rupall (Canada), Rasuvo (US), Metoject (Canada), and Gleolan (US). IXINITY (US) is an intravenous recombinant factor IX therapeutic for use in patients with hemophilia B. Rupall (Canada) is a prescription allergy medication with a mode of action. Rasuvo (US) and Metoject (Canada) is a formulation of methotrexate designed to treat rheumatoid arthritis and other autoimmune diseases. Gleolan (US) is an optical imaging agent indicated in patients with glioma as an adjunct for the visualization of malignant tissue during surgery.

Webull offers Medexus Pharmaceuticals Inc stock information, including OTCQX: MEDXF real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, MEDXF stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading MEDXF stock methods without spending real money on the virtual paper trading platform.